Market Overview:
The global drug abuse testing market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The growth in the market can be attributed to the increasing number of drug-related deaths, growing awareness about drug abuse, and rising demand for drugs tests in schools and educational institutes, hospitals and healthcare units, government and private departments. However, the high cost of drugs tests is expected to restrain the growth of this market during the forecast period. On the basis of type, random testing accounted for majority share in 2017 and is projected to maintain its dominance during forecast period. This can be attributed to increasing number of random drug tests conducted by various organizations across different regions.
Product Definition:
Drug abuse testing is the use of various tests to determine whether a person has been using drugs. The main types of drug abuse tests are urine tests, saliva tests, blood tests, and hair follicle tests. Drug abuse testing is important because it can help people who are addicted to drugs get the help they need. It can also help employers ensure that their employees are not using drugs while at work.
Random Testing:
The global random testing market size was valued at USD 2.1 billion in 2015 and is expected to grow at a CAGR of XX% over the forecast period. The rising number of drug abuse cases across the globe has led to an increase in demand for accurate, reliable and rapid tests that can identify substances other than alcohol and tobacco as well as aid in identifying new drugs present on samples taken from patients suffering from substance abuse disorders.
Reasonable Testing:
Reasonable testing is a method used by laboratories to determine the accuracy of their analytical results. It involves two steps, sample collection and analysis. The samples are sent to an independent party for analysis which includes chemistry, biochemistry and toxicology tests. This helps in minimizing errors that may occur during the process thus increasing the reliability of test results.
Application Insights:
Based on application, the market is segmented into schools and educational institutes, government and private departments, hospitals and healthcare units. Government departments held the largest share in 2017 owing to increasing drug abuse cases across countries. For instance, according to National Drug Abuse hotline 1-800-622-HELP of U.S., around 4 out of 10 high school students have tried drugs or alcohol (2017). Such trends are expected to increase pressure on governments for implementing effective drug abuse management policies at district level resulting in high demand for ADDT services from government departmental laboratories across the world.
Hospitals & healthcare units are anticipated to witness lucrative growth over forecast period due largely to rising incidences of substance abuse disorders coupled with a rise in number of detoxification facilities across regions including India, China Australia New Zealand among others.
Regional Analysis:
Asia Pacific is estimated to be the fastest growing region over the forecast period. The growth of this region can be attributed to increasing cases of substance abuse in countries, such as India and China. According to a study published by National Center for Biotechnology Information (NCBI), drug abuse has been observed in 1% - 3% population of China while 0.5% - 1% population suffers from alcohol use disorder.
North America held a significant share owing to high demand for workplace drug testing services coupled with strict laws regarding driving under the influence of alcohol or drugs by states like California and Florida that have legalized marijuana use for medical purposes after obtaining approval from state governments.
Growth Factors:
- Increasing incidences of drug abuse and addiction across the globe is expected to drive the demand for drug abuse testing market over the forecast period.
- Growing awareness about various types of drugs and their effects is anticipated to fuel the growth of this market in near future.
- Stringent government regulations pertaining to safe workplace environment are projected to propel the demand for drug abuse testing products and services over the next few years.
- Rising number of rehabilitation centers worldwide is likely to create lucrative opportunities for key players operating in this market during forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Drug Abuse Testing Market Research Report
By Type
Random Testing, Reasonable Testing, Post accident Testing, Follow-up Testing
By Application
Schools and Educational Institutes, Hospitals and Healthcare Units, Government and Private Departments
By Companies
Biomedical Diagnostics, BioMerieux, Abbott, Bio-Rad, Dako, DiaSorin, Eiken, Fujirebio, Beckman Coulter
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
192
Number of Tables & Figures
135
Customization Available
Yes, the report can be customized as per your need.
Global Drug Abuse Testing Market Report Segments:
The global Drug Abuse Testing market is segmented on the basis of:
Types
Random Testing, Reasonable Testing, Post accident Testing, Follow-up Testing
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Schools and Educational Institutes, Hospitals and Healthcare Units, Government and Private Departments
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Biomedical Diagnostics
- BioMerieux
- Abbott
- Bio-Rad
- Dako
- DiaSorin
- Eiken
- Fujirebio
- Beckman Coulter
Highlights of The Drug Abuse Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Random Testing
- Reasonable Testing
- Post accident Testing
- Follow-up Testing
- By Application:
- Schools and Educational Institutes
- Hospitals and Healthcare Units
- Government and Private Departments
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Drug Abuse Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Drug abuse testing is a process used to determine if an individual has abused drugs. This can be done by analyzing a sample of the individual's urine or blood.
Some of the major companies in the drug abuse testing market are Biomedical Diagnostics, BioMerieux, Abbott, Bio-Rad, Dako, DiaSorin, Eiken, Fujirebio, Beckman Coulter.
The drug abuse testing market is expected to register a CAGR of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Drug Abuse Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Drug Abuse Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Drug Abuse Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Drug Abuse Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Drug Abuse Testing Market Size & Forecast, 2020-2028
4.5.1 Drug Abuse Testing Market Size and Y-o-Y Growth
4.5.2 Drug Abuse Testing Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Random Testing
5.2.2 Reasonable Testing
5.2.3 Post accident Testing
5.2.4 Follow-up Testing
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Schools and Educational Institutes
6.2.2 Hospitals and Healthcare Units
6.2.3 Government and Private Departments
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Drug Abuse Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Drug Abuse Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Random Testing
9.6.2 Reasonable Testing
9.6.3 Post accident Testing
9.6.4 Follow-up Testing
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Schools and Educational Institutes
9.10.2 Hospitals and Healthcare Units
9.10.3 Government and Private Departments
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Random Testing
10.6.2 Reasonable Testing
10.6.3 Post accident Testing
10.6.4 Follow-up Testing
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Schools and Educational Institutes
10.10.2 Hospitals and Healthcare Units
10.10.3 Government and Private Departments
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Random Testing
11.6.2 Reasonable Testing
11.6.3 Post accident Testing
11.6.4 Follow-up Testing
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Schools and Educational Institutes
11.10.2 Hospitals and Healthcare Units
11.10.3 Government and Private Departments
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Random Testing
12.6.2 Reasonable Testing
12.6.3 Post accident Testing
12.6.4 Follow-up Testing
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Schools and Educational Institutes
12.10.2 Hospitals and Healthcare Units
12.10.3 Government and Private Departments
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Random Testing
13.6.2 Reasonable Testing
13.6.3 Post accident Testing
13.6.4 Follow-up Testing
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Schools and Educational Institutes
13.10.2 Hospitals and Healthcare Units
13.10.3 Government and Private Departments
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Drug Abuse Testing Market: Competitive Dashboard
14.2 Global Drug Abuse Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Biomedical Diagnostics
14.3.2 BioMerieux
14.3.3 Abbott
14.3.4 Bio-Rad
14.3.5 Dako
14.3.6 DiaSorin
14.3.7 Eiken
14.3.8 Fujirebio
14.3.9 Beckman Coulter
